E-LIB Suche - Ergebnisse für: Zatloukal, P.

1

Erlotinib treatment results in patients with advanced non-s..:

Salajka, F. ; Pešek, M. ; Skřičková, J....
Lung Cancer. 77 (2012) - p. S36-S37 , 2012

Link: https://doi.org/10.1016/..

2

Group of patients with NSCLC treated with erlotinib in the ..:

Grygárková, I. ; Kolek, V. ; Skřičková, J....
Lung Cancer. 77 (2012) - p. S31 , 2012

Link: https://doi.org/10.1016/..

3

Overall survival with cisplatin–gemcitabine and bevacizumab..:

Reck, M. ; von Pawel, J. ; Zatloukal, P....
Annals of Oncology. 21 (2010) 9 - p. 1804-1809 , 2010

Link: https://doi.org/10.1093/..

4

6503 ORAL Efficacy and safety results from BO17704, a rando..:

Manegold, C. ; vonPawel, J. ; Zatloukal, P....
European Journal of Cancer Supplements. 5 (2007) 4 - p. 357 , 2007

Link: https://doi.org/10.1016/..

5

6501 ORAL Global Lung Oncology Branch trial 3 (GLOB 3): Qua..:

Rolski, J. ; Grodzki, T. ; Schneider, C.P....
European Journal of Cancer Supplements. 5 (2007) 4 - p. 356 , 2007

Link: https://doi.org/10.1016/..

6

1229 POSTER The importance of environmental and lifestyle f..:

Kubik, A. ; Zatloukal, P. ; Tomasek, L...
European Journal of Cancer Supplements. 5 (2007) 4 - p. 169 , 2007

Link: https://doi.org/10.1016/..

7

6570 POSTER Results for progression-free survival (PFS) fro..:

Sandler, A. ; Reck, M. ; vonPawel, J....
European Journal of Cancer Supplements. 5 (2007) 4 - p. 379 , 2007

Link: https://doi.org/10.1016/..

8

6509 ORAL Management of hypertension (HTN) in patients with..:

Bennouna, J. ; vonPawel, J. ; Zatloukal, P....
European Journal of Cancer Supplements. 5 (2007) 4 - p. 359 , 2007

Link: https://doi.org/10.1016/..

9

6518 ORAL Subgroup results from a randomised, double-blind,..:

Eberhardt, W. ; Reck, M. ; vonPawel, J....
European Journal of Cancer Supplements. 5 (2007) 4 - p. 362 , 2007

Link: https://doi.org/10.1016/..

10

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-L..:

Ardizzoni, A. ; Boni, L. ; Tiseo, M....
JNCI Journal of the National Cancer Institute. 99 (2007) 11 - p. 847-857 , 2007

Link: https://doi.org/10.1093/..

11

P-562 Evaluation of bexarotene (Targretine®) in combination..:

Ramlau, R. ; Zatloukal, P. ; Tadokoro, H....
Lung Cancer. 49 (2005) - p. S266 , 2005

Link: https://doi.org/10.1016/..

12

Clinical Correlations of Potential Activity Markers in Syst..:

BEČVÁŘ, R. ; ŠTORK, J. ; PEŠÁKOVÁ, V....
Annals of the New York Academy of Sciences. 1051 (2005) 1 - p. 404-412 , 2005

Link: https://doi.org/10.1196/..

13

O-163 Prevention of thromboembolic complications with the l..:

Gatzemeier, U. ; Freund, M. ; Haas, S....
Lung Cancer. 49 (2005) - p. S56 , 2005

Link: https://doi.org/10.1016/..

14

P-069 Expression of transcripts encoding apoptotic protease..:

Krepela, E. ; Prochazka, J. ; Fiala, P...
Lung Cancer. 49 (2005) - p. S132 , 2005

Link: https://doi.org/10.1016/..

15

P-592 Effect of bexarotene on vinorelbine and cisplatinphar..:

Wakelee, H. ; Middleton, G. ; Dunlop, D....
Lung Cancer. 49 (2005) - p. S274 , 2005

Link: https://doi.org/10.1016/..